Introduction to Molecular Testing In Ovarian Cancer
Exploring Molecular Testing In Ovarian Cancer reveals several interesting facts. Bradley J. Monk, MD, and Angeles Alvarez Secord, MD, explain histological subtypes and gene mutations found in
Molecular Testing In Ovarian Cancer Comprehensive Overview
Bradley J. Monk, MD, FACS, FACOG; Kathleen Moore, MD; Leslie M. Randall, MD, MAS; Oliver Dorigo, MD, PhD; and Thomas ... Whitney S. Graybill, MD, MS, discusses the clinical use of BRCA1/2 Bradley J. Monk, MD, FACS, FACOG; David O'Malley, MD; Ursula Matulonis, MD; Shannon N. Westin, MD, MPH; and Matthew ...
Learn more about
Summary & Highlights for Molecular Testing In Ovarian Cancer
- Presenter: Rob Dood, MD, Department of Obstetrics & Gynecology, Division of Gynecology
- Sarah E. Taylor, MD, discusses
- Watch Dr ElNaggar discuss the clinical utility of homologous recombination deficiency (HRD) and how
- Oliver Dorigo, MD, PhD, and Matthew Powell, MD, share insight on how to optimize
- The Society for Women's Health Research presents an introduction to the exciting field of
Stay tuned for more updates related to Molecular Testing In Ovarian Cancer.
